A study being published in the upcoming issue of the Journal of Neuroimmune Pharmacology, and e-published ahead of print yesterday (July 12, 2014) by the U.S. National Institute of Health (who also conducted the study), has found that cannabinoid agonists – such as cannabis – may attenuate HIV-associated neuro cognitive disorders in HIV patients on HAART (highly active antiretroviral therapy). The study also found that activation of the body’s cannabinoid receptors may “blunt brain injury by attenuating drug addiction”.
Medical Cannabis News & Information
Earlier this month, Berkeley’s City Council voted unanimously for an ordinance that would provide free medical marijuana to patients with low incomes. If the ordinance passes its second reading in August, marijuana dispensaries will have to set aside 2 percent of their product — which must be of equivalent quality to the marijuana they’re selling at market prices — and give it free to city residents with incomes below $32,000.
New York became the 23rd state in the US to legalize medical marijuana. Though Governor Andrew Cuomo signed the bill Saturday, it will be at least another 18 months before medical marijuana becomes available in New York for patients, something parents of children in need of the treatment fear.
Does cannabis treat cancer? Does cannabis kill cancer cells? Does it cure cancer?
THC Magazine posed those questions, in that order, to one of the most knowledgeable people on Earth: Dr. Robert Melamede, a University of Colorado biology professor and world-renowned cannabis researcher.
We also painstakingly reviewed dozens of preclinical studies on cannabis. Our goal is to understand whether cannabis could be the kiss of death for cancer, a panacea for the most feared diseases on the planet.
A study published recently in the International Journal of High Risk Behavior and Addiction, and published online by the U.S. National Institute of Health, has found that cannabinoids may treat the symptoms of a large variety of neurodegernative diseases including multiple sclerosis, amyotrophic lateral sclerosis, Huntington’s disease, Parkinson’s disease and Alzheimer’s disease.
“The aim of this review is to highlight the role of endocannabinoid system in neurodegenerative diseases”, claims the abstract of the study, which researchers call “a critical analysis of the most recent data currently present in scientific literature on the subject; a qualitative synthesis of only the most significant articles has been performed.”